BioNTech SE (BNTX) Operating Expenses (2018 - 2025)

BioNTech SE has disclosed Operating Expenses across 8 years of filings, most recently posting -$784.6 million for Q4 2025.

• Operating Expenses for Q4 2025 came in at -$784.6 million, down 1.61% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.0 billion (up 1.74% YoY), and the FY2025 annual result was -$3.0 billion, up 0.57% from the prior year.
• Operating Expenses came in at -$784.6 million for Q4 2025 at BioNTech SE, up from -$802.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$299.7 million in Q2 2021 to a low of -$813.6 million in Q2 2024.
• The 5-year median for Operating Expenses is -$653.9 million (2022), against an average of -$600.6 million.
• Across the five-year window, Operating Expenses slumped 1511.72% in 2021 and climbed 12.79% in 2025, its largest moves.
• BioNTech SE's Operating Expenses stood at -$460.3 million in 2021, then slumped by 39.56% to -$642.4 million in 2022, then dropped by 17.58% to -$755.4 million in 2023, then decreased by 2.22% to -$772.2 million in 2024, then fell by 1.61% to -$784.6 million in 2025.
• The last three Operating Expenses figures came in at -$784.6 million (Q4 2025), -$802.0 million (Q3 2025), and -$709.5 million (Q2 2025), per Business Quant data.